DHSC0006168_083 - Hansard written answer on BPL policy for withdrawal of blood products implicated in CJD - 19 Dec 2000

Parliamentary Question PQ 320 from Jim Cousens to ask the Secretary of State for Health re Policy that userpatients should be informed if the Bio Products Laboratory withdraws blood products due to CJD protection requirements and Suggested Reply